A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositisAdam Schiffenbauer, Mark F. Gourley, Joseph A. Shrader et al.|Seminars in Arthritis and Rheumatism|2017Cited by 70